How do you choose between or identify the right patient for Zytiga or Xtandi?

Nicholas J. Vogelzang, MD of Comprehensive Cancer Centers of Nevada explains how he chooses the right prostate cancer patient for Zytiga (abiraterone acetate) or Xtandi (enzalutamide) at the 2017 ASCO... Author: obr Added: 06/23/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts